FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 107 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q2 2022. The put-call ratio across all filers is 6.48 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $72,464,000 | +237.2% | 3,632,271 | +16.5% | 0.00% | +100.0% |
| Q2 2022 | $21,489,000 | -23.4% | 3,119,060 | +3.3% | 0.00% | 0.0% |
| Q1 2022 | $28,069,000 | -34.8% | 3,018,285 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $43,039,000 | -45.6% | 3,026,666 | -11.2% | 0.00% | -50.0% |
| Q3 2021 | $79,070,000 | -4.7% | 3,409,686 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $82,986,000 | -10.0% | 3,334,125 | +1.4% | 0.00% | -33.3% |
| Q1 2021 | $92,176,000 | +0.2% | 3,289,576 | +24.9% | 0.00% | 0.0% |
| Q4 2020 | $91,952,000 | +26.6% | 2,634,750 | +80.7% | 0.00% | 0.0% |
| Q3 2020 | $72,655,000 | +179.2% | 1,457,768 | +160.4% | 0.00% | +200.0% |
| Q2 2020 | $26,027,000 | – | 559,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |